Turning the tide: knowledge promotes health (Spanish SP)
244 views · Published 13 July 2017 · 2:09 · Indexed 20 September 2026
Channel: Philips · 2017 · Science & Technology
Discover how Philips ElastPQ gives Chinese doctors valuable data that can help diagnose liver cancer. See our stories of how Philips innovations are improving peoples' lives around the world at http://philips.com/innovationandyou At Philips, we're here to deliver innovation that matters to you. Others may focus on what innovation does. We focus on what it does for you. Learn more about Philips innovations at http://www.philips.com Follow us on Twitter at https://twitter.com/philips Follow us on Facebook at https://www.facebook.com/Philips "Turning the tide: knowledge promotes health" video transcript: TITLE CARD: Turning the Tide: Chengdu, China DR. YAN LUO: This hospital is of huge scale.We have more than 4,300 beds. SUPER: Dr. Yan Luo: Director, Ultrasound Dept., West China Hospital Globally, China accounts for more than half of the new cases -- and deaths -- from liver cancer. SUPER: Dr. Wu Ling: Ultrasound Dept., West China Hospital Some old technologies can be intrusive. There's a high cost and burden for the patients. Some new technologies are more affordable, especially the ElastPQ from Philips. The ElastPQ is non-intrusive, while providing more detailed information for diagnosis. DR. YAN LUO: We began a research project with Philips' Ultrasound Institute on liver cancer elasticity two years ago. We have sampled over 1,200 cases. So far, we've already published one scientific paper. DR. WU LING: Our paper supports the new technology and also details the clinical applications. So that everyone can repeat the same results. DR. YAN LUO: The Philips team has a lot of resources, including scientists with engineering backgrounds. Having joined forces, we're bridging the gap to match better technology with actual clinical needs. We raise new questions in the process of solving problems. This evolving cycle helps us to continuously innovate. Today the focus is on liver cancer, but I hope to expand our collaboration to other areas. Our ultimate goal is to provide faster and more accurate diagnosis and treatment for patients.
